CompanyLSTANasdaqBasking Ridge, NJ

Lisata Therapeutics, Inc.

Lisata Therapeutics develops cyclic peptide therapies for advanced solid tumors.

SEC EDGAR ClinicalTrials.gov lisata.com

8-KSep 17Latest SEC filing, period to Sep 17

Sep 17Latest story

September 2026

Lisata acquires Marea Therapeutics, raises $225 million in private placement

Sep 17M&ALisata Therapeutics, Inc.

August 2026

Lisata cuts 72% of workforce, terminates CMO amid Kuva Labs merger dispute

Aug 4RestructuringLisata Therapeutics, Inc.

July 2026

Lisata terminates Kuva Labs merger after failed financing for tender offer

Jul 24PartnershipLisata Therapeutics, Inc.